-
Founded in:
1992-07-14 -
Country:
China -
Address:
Guilinyang Economic Development Zone, Meilan District, Haikou City -
Tax NO.:
91460000620000247L -
Registered Funds:
448.350021 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nimodipine |
Extract from the above information
More
Extract from the above information |
66085-59-4 | 18 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 4-[2-[[1-methyl-3-(4-hydroxyphenyl)propyl]amino]ethyl]-1,2-benzenediol hydrochloride |
1. It has a positive inotropic effect on the myocardium, mainly acting on β1 receptors, and has relatively little effect on β2 and α receptors. 2. It can directly excite cardiac β1 receptors to enhance myocardial contraction and increase stroke volume, thereby increasing cardiac output. 3. It can reduce peripheral vascular resistance (reduced afterload), but systolic blood pressure and pulse pressure generally remain unchanged, or only increase due to increased cardiac output. 4. It can reduce ventricular filling pressure and promote atrioventricular node conduction. 5. Myocardial contractility is enhanced, and coronary blood flow and myocardial oxygen consumption often increase. 6. Due to increased cardiac output, renal blood flow and urine volume often increase.
More
1. It has a positive inotropic effect on the myocardium, mainly acting on β1 receptors, and has relatively little effect on β2 and α receptors. 2. It can directly excite cardiac β1 receptors to enhance myocardial contraction and increase stroke volume, thereby increasing cardiac output. 3. It can reduce peripheral vascular resistance (reduced afterload), but systolic blood pressure and pulse pressure generally remain unchanged, or only increase due to increased cardiac output. 4. It can reduce ventricular filling pressure and promote atrioventricular node conduction. 5. Myocardial contractility is enhanced, and coronary blood flow and myocardial oxygen consumption often increase. 6. Due to increased cardiac output, renal blood flow and urine volume often increase. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clotrimazole |
|
23593-75-1 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clotrimazole |
|
23593-75-1 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clotrimazole |
Not clearly described
More
Not clearly described |
23593-75-1 | 46 |